I now have comprehensive content from Lippincott. Let me compile the full easy notes:
π§ͺ Chemotherapy - Easy Notes
Source: Lippincott Illustrated Reviews: Pharmacology
1. What is Chemotherapy?
Chemotherapy uses chemical drugs to kill or slow the growth of cancer cells. It works mainly by targeting rapidly dividing cells. About 10% of cancer patients achieve cure/prolonged remission with chemo alone; in most cases it produces regression but not a cure. The overall 5-year survival for cancer patients is ~68%.
2. Key Concepts
| Term | Meaning |
|---|
| Cell cycle specific | Drug works only in a specific phase (e.g., S phase) |
| Cell cycle non-specific | Drug works in any phase, including resting cells |
| Myelosuppression | Bone marrow suppression - most common side effect |
| Nadir | Lowest point of blood cell counts after chemo |
| Combination therapy | Multiple drugs used together to increase efficacy and reduce resistance |
3. Classes of Chemotherapy Drugs
A. Alkylating / Adducting Agents
Mechanism: Cross-link DNA strands, preventing replication. Cell cycle non-specific.
| Drug | Key Notes |
|---|
| Cyclophosphamide | Prodrug; activated by liver CYP450. Unique toxicity = hemorrhagic cystitis (prevented by Mesna + hydration) |
| Ifosfamide | Similar to cyclophosphamide; also causes hemorrhagic cystitis. Neurotoxicity from chloroacetaldehyde metabolite |
| Cisplatin / Carboplatin | Platinum compounds; cross-link DNA. Cisplatin = nephrotoxic + ototoxic; carboplatin = less toxic |
| Carmustine / Lomustine (Nitrosoureas) | Penetrate the CNS - used for brain tumors. Delayed myelosuppression (4-6 weeks) |
| Busulfan | Used in CML and bone marrow transplant prep. Causes pulmonary fibrosis |
Mnemonic: "Alkylating agents CROSS the DNA bridge"
B. Antimetabolites
Mechanism: Mimic normal building blocks of DNA/RNA; block their synthesis. Cell cycle specific - S phase.
| Drug | Class | Key Notes |
|---|
| Methotrexate (MTX) | Folate analog | Inhibits DHFR. Toxicity rescued by leucovorin. Nephrotoxic at high doses |
| 5-Fluorouracil (5-FU) | Pyrimidine analog | Inhibits thymidylate synthase. Side effect: hand-foot syndrome, mucositis |
| Capecitabine | Pyrimidine analog | Oral prodrug of 5-FU. Also causes hand-foot syndrome |
| 6-Mercaptopurine (6-MP) | Purine analog | Reduce dose by 50-75% with allopurinol (to prevent toxicity) |
| Cytarabine (Ara-C) | Pyrimidine analog | Used in leukemias. High-dose causes cerebellar toxicity |
| Gemcitabine | Pyrimidine analog | Used in pancreatic, lung, bladder cancer |
| Fludarabine | Purine analog | Used in CLL. Causes immunosuppression |
Mnemonic: "Antimetabolites are Fake Nucleotides"
C. Antibiotics (Antitumor)
Mechanism: Intercalate DNA, generate free radicals, inhibit topoisomerase II.
| Drug | Key Notes |
|---|
| Doxorubicin (Adriamycin) | Most widely used. Causes cardiomyopathy (dose-dependent); use dexrazoxane for cardiac protection |
| Bleomycin | Causes pulmonary fibrosis (unique lung toxicity). Used in testicular cancer, Hodgkin lymphoma |
| Daunorubicin | Used in AML/ALL; also cardiotoxic |
D. Plant Alkaloids
Vinca Alkaloids (from periwinkle plant)
Mechanism: Bind tubulin, prevent spindle formation β cell arrest in M phase.
| Drug | Key Notes |
|---|
| Vincristine | Peripheral neuropathy (dose-limiting). Minimal myelosuppression |
| Vinblastine | Myelosuppression (dose-limiting). Less neuropathy |
Taxanes
Mechanism: Stabilize microtubules (prevent disassembly) β block mitosis.
| Drug | Key Notes |
|---|
| Paclitaxel (Taxol) | Used in breast, ovarian, lung cancer. Causes peripheral neuropathy, hypersensitivity |
| Docetaxel | Similar to paclitaxel |
Topoisomerase Inhibitors
| Drug | Type | Key Notes |
|---|
| Etoposide (VP-16) | Topo II inhibitor | Used in lung cancer, lymphoma |
| Irinotecan / Topotecan | Topo I inhibitors (Camptothecins) | Diarrhea is dose-limiting side effect |
E. Hormonal Agents
Used mainly in hormone-sensitive cancers (breast, prostate).
| Drug | Mechanism | Use |
|---|
| Tamoxifen | SERM - blocks estrogen receptors | ER+ breast cancer |
| Letrozole / Anastrozole | Aromatase inhibitors | Post-menopausal breast cancer |
| Leuprolide / Goserelin | GnRH agonists (cause hormone ablation) | Prostate cancer |
| Flutamide / Bicalutamide | Androgen receptor blockers | Prostate cancer |
F. Targeted Therapy
Monoclonal Antibodies (end in -mab)
| Drug | Target | Use |
|---|
| Trastuzumab (Herceptin) | HER2/neu | HER2+ breast cancer |
| Rituximab | CD20 | B-cell lymphoma |
| Bevacizumab | VEGF (anti-angiogenesis) | Colorectal, lung, ovarian cancer |
| Cetuximab | EGFR | Colorectal, head & neck cancer |
Kinase Inhibitors (end in -nib)
| Drug | Target | Use |
|---|
| Imatinib (Gleevec) | BCR-ABL tyrosine kinase | CML (Philadelphia chromosome+) |
| Erlotinib | EGFR | Non-small cell lung cancer |
| Vemurafenib | BRAF V600E mutation | Melanoma |
G. Immunotherapy (Checkpoint Inhibitors)
Mechanism: Block PD-1, PD-L1, or CTLA-4 to "unleash" the immune system against cancer.
| Drug | Target | Use |
|---|
| Pembrolizumab (Keytruda) | PD-1 | Melanoma, NSCLC, many others |
| Nivolumab (Opdivo) | PD-1 | Melanoma, RCC, NSCLC |
| Atezolizumab | PD-L1 | Bladder, NSCLC |
| Ipilimumab (Yervoy) | CTLA-4 | Melanoma |
Side effects: Immune-related adverse events (irAEs) - colitis, pneumonitis, hepatitis, endocrinopathies
4. Common Side Effects Summary
| Side Effect | Drugs Responsible |
|---|
| Myelosuppression | Almost all chemo drugs |
| Nausea/Vomiting | Cisplatin (most emetogenic), cyclophosphamide |
| Alopecia | Doxorubicin, cyclophosphamide |
| Cardiomyopathy | Doxorubicin, daunorubicin |
| Pulmonary fibrosis | Bleomycin, busulfan |
| Hemorrhagic cystitis | Cyclophosphamide, ifosfamide β prevented by Mesna |
| Nephrotoxicity | Cisplatin β give IV fluids + amifostine |
| Peripheral neuropathy | Vincristine, paclitaxel, cisplatin |
| Ototoxicity | Cisplatin |
| Hand-foot syndrome | 5-FU, capecitabine |
| Neurotoxicity (CNS) | High-dose cytarabine (cerebellar), ifosfamide |
5. Cell Cycle Targets - Quick Visual
G1 (Growth) β S phase (DNA synthesis) β G2 β M phase (Mitosis)
β β
Antimetabolites Vinca alkaloids
(Methotrexate, 5-FU) Taxanes
Etoposide
Alkylating agents, Antibiotics (Doxorubicin) β Cell Cycle NON-specific
6. Important Drug Interactions to Remember
| Drug | Interaction | Effect |
|---|
| Methotrexate + NSAIDs | NSAIDs decrease MTX excretion | Increased MTX toxicity |
| 6-MP + Allopurinol | Allopurinol inhibits xanthine oxidase (metabolizes 6-MP) | Increase 6-MP levels β reduce dose 50-75% |
| Cyclophosphamide | Enhanced toxicity with other immunosuppressants | |
| Leucovorin | "Rescue" after high-dose MTX | Reverses folate depletion |
7. Quick Mnemonics
- "MOPP" - Classic Hodgkin lymphoma regimen: Mechlorethamine, Oncovin (vincristine), Procarbazine, Prednisone
- "ABVD" - Modern Hodgkin regimen: Adriamycin (doxorubicin), Bleomycin, Vinblastine, Dacarbazine
- "CMF" - Breast cancer: Cyclophosphamide, Methotrexate, 5-Fluorouracil
- "Bleomycin = Breathe-o-mycin" β lung toxicity (pulmonary fibrosis)
- "Cis-PLATin" β think PLATinum β nephrotoxic, give PLENTY of fluids
Source: Lippincott Illustrated Reviews: Pharmacology, Chapter 37 - Anticancer Drugs